A. V. Bondarev
A. V. Bondarev has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Natalia B. Demina
I. M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Anastasiya Yu. Malyutina
Belgorod National State Research University of the Russian Federation 85, Pobeda Str. 308015 Belgorod Russia
1 shared publication - D. K. Naplekov
Federal State Autonomous Educational Institution of Higher Education «Belgorod State University
1 shared publication E. T. Zhilyakova
Belgorod National Research University
1 shared publicationE. Yu. Timoshenko
Belgorod National Research University
1 shared publication- Elena Teodorovna Zhilyakova
Belgorod State National Research University
1 shared publication
Latest Publications
- Open Access
- 26 November 2020
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 9 (4) , 59-64
New Approach to Drug Delivery in Ophthalmological Practice: Development of Composite Ophthalmological Solution for Drug Loading of Soft Contact Lenses
Introduction. This article provides a tentative justification of use of soft contact lenses as a carrier of ophthalmological solutions to eye tissues.Aim. The aim of the research is to develop the composition of the ophthalmic transport system for the treatment of glaucoma. Also, the proposed manufacturing algorithms were proposed for drug loading ophthalmological solutions.Materials and methods. Preparation of sodium hyaluronate solution was carried out based on the methodology described in EP 7.0 [01/2011:1472] (Sodium hyaluronate).Results and discussion. The conducted investigation with the purpose to justify a concentration of sodium hyaluronate helped to determine its concentration that gives the viscosity level as close to the upper limit stated in Russian Pharmacopoeia as possible. Buffer solution was chosen with criteria to use as less components in ophthalmological solution as possible. Also, it was found out that the more components are added to the viscous solution, the more viscosity level is decreased. Thus, initial viscosity of solution containing sodium hyaluronate was 149.59 mm2/s, and after addition of active pharmaceutical substance it dropped down to 88.49 mm2/s and 81.36 mm2/s for model solution number 1 and 2, respectively. After addition of citric acid and disodium hydrophosphate, the viscosity of model solution was found to be 78.11 mm2/s and 75.28 mm2/s for model solution number 1 and 2, respectively.Conclusion. As a result of the studies, two alternative model compositions of an ophthalmic solution for the saturation of soft contact lenses for the treatment of glaucoma were proposed. The choice of active pharmaceutical substances, and excipients has been justified. Technological procedure of preparation of model solution was described and explained, where the most attention was paid on dissolving of sodium hyaluronate in purified water.
- 26 November 2020
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 9 (4) , 59-64
Open AccessNew Approach to Drug Delivery in Ophthalmological Practice: Development of Composite Ophthalmological Solution for Drug Loading of Soft Contact Lenses
Introduction. This article provides a tentative justification of use of soft contact lenses as a carrier of ophthalmological solutions to eye tissues.Aim. The aim of the research is to develop the composition of the ophthalmic transport system for the treatment of glaucoma. Also, the proposed manufacturing algorithms were proposed for drug loading ophthalmological solutions.Materials and methods. Preparation of sodium hyaluronate solution was carried out based on the methodology described in EP 7.0 [01/2011:1472] (Sodium hyaluronate).Results and discussion. The conducted investigation with the purpose to justify a concentration of sodium hyaluronate helped to determine its concentration that gives the viscosity level as close to the upper limit stated in Russian Pharmacopoeia as possible. Buffer solution was chosen with criteria to use as less components in ophthalmological solution as possible. Also, it was found out that the more components are added to the viscous solution, the more viscosity level is decreased. Thus, initial viscosity of solution containing sodium hyaluronate was 149.59 mm2/s, and after addition of active pharmaceutical substance it dropped down to 88.49 mm2/s and 81.36 mm2/s for model solution number 1 and 2, respectively. After addition of citric acid and disodium hydrophosphate, the viscosity of model solution was found to be 78.11 mm2/s and 75.28 mm2/s for model solution number 1 and 2, respectively.Conclusion. As a result of the studies, two alternative model compositions of an ophthalmic solution for the saturation of soft contact lenses for the treatment of glaucoma were proposed. The choice of active pharmaceutical substances, and excipients has been justified. Technological procedure of preparation of model solution was described and explained, where the most attention was paid on dissolving of sodium hyaluronate in purified water.
- Open Access
- 26 November 2019
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 8 (4) , 27-31-31
Prospects for the Use of Medical Clays (Review)
Introduction. The article deals with the aspects of the use of Medical Clays in Pharmaceutical Technology. A review of the traditional areas of application of Medical Clay, as well as highlighting new directions.Text. One of the main problems of domestic industrial pharmacy is a narrow nomenclature of active pharmaceutical substances and excipients. Replenishment of the nomenclature occurs in two ways-through the synthesis of new chemical compounds or through the processing of natural raw materials of animal, plant or mineral origin. In the process of purification and processing of mineral raw materials, Medical Clays are obtained, which are now widely used as active pharmaceutical substances for the production of Enterosorbents, as well as auxiliary substances.Conclusion. A review of perspectives and areas of use of Medicinal Clays have shown that at present, Medical Clays used in the three traditional areas: cutaneous application, application per os, application in pharmaceutical and food technology. A promising direction is the use of Medical Clays as transport drug systems. The study of this information array and its generalization has undoubted practical and scientific significance in modern pharmaceutical technology.
- 26 November 2019
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 8 (4) , 27-31-31
Open AccessProspects for the Use of Medical Clays (Review)
Introduction. The article deals with the aspects of the use of Medical Clays in Pharmaceutical Technology. A review of the traditional areas of application of Medical Clay, as well as highlighting new directions.Text. One of the main problems of domestic industrial pharmacy is a narrow nomenclature of active pharmaceutical substances and excipients. Replenishment of the nomenclature occurs in two ways-through the synthesis of new chemical compounds or through the processing of natural raw materials of animal, plant or mineral origin. In the process of purification and processing of mineral raw materials, Medical Clays are obtained, which are now widely used as active pharmaceutical substances for the production of Enterosorbents, as well as auxiliary substances.Conclusion. A review of perspectives and areas of use of Medicinal Clays have shown that at present, Medical Clays used in the three traditional areas: cutaneous application, application per os, application in pharmaceutical and food technology. A promising direction is the use of Medical Clays as transport drug systems. The study of this information array and its generalization has undoubted practical and scientific significance in modern pharmaceutical technology.